Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Ampyra (Fampyra)
The effects of diet on the severity of central nervous system disease: One part of lab-to-lab variability.
Dimethyl fumarate inhibits the expression and function of hypoxia-inducible factor-1α (HIF-1α).
LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons.
The absence of 25-hydroxyvitamin D3-1α-hydroxylase potentiates the suppression of EAE in mice by ultraviolet light.
Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder.
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.
Multiple sclerosis and risk of young-adult-onset Hodgkin lymphoma.
Glial cells as drug targets: What does it take?
Opinion: Focus on preclinical sex differences will not address women's and men's health disparities.
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab.
Clinical Reasoning: Left hemiparesis, ataxia, and optic neuritis in a child previously treated for pineoblastoma.
Polymorphism in Leptin and Leptin Receptor Genes May Modify Leptin Levels and Represent Risk Factors for Multiple Sclerosis.
Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy.
Two cases of relapses in primary progressive multiple sclerosis after fingolimod withdrawal.
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.
Prevalence of people who could benefit from augmentative and alternative communication (AAC) in the UK: determining the need.
Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.
Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate.
Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes.
Glatiramer Acetate Protects Against Inflammatory Synaptopathy in Experimental Autoimmune Encephalomyelitis.
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis.
CHMP determines dimethyl fumarate in TECFIDERA® to be a new active substance in the European Union
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.

Pages